0

Telemedicine for High Blood Pressure

SC
Overseen BySunit Chhetri
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of study is to understand the different factors (patient, societal, provider, clinic, health system) relevant in recruitment and participation of patients in Team Based Equity Conscious Telemedicine Approach to Improve Hypertension clinical trial.

Research Team

YP

Yashashwi Pokharel, MD, MSCR

Principal Investigator

Wake Forest University Health Sciences

Eligibility Criteria

This trial is for individuals with high blood pressure. It aims to understand various factors affecting patient recruitment and participation in a telemedicine approach tailored to hypertension management.

Inclusion Criteria

African American or Black
Patients with last clinic systolic Blood Pressure >140 mmHg or diastolic Blood Pressure >90 mmHg or both

Exclusion Criteria

Diminished ability to measure home BP (dementia, or psychosis)
I've had recent health issues that could affect my blood pressure.
Terminal illness

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the TET-HTN intervention over six months

6 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Team Based Equity Conscious Telemedicine Hypertension Intervention
Trial Overview The study is testing the effectiveness of a team-based, equity-focused telemedicine intervention for managing high blood pressure compared to usual care. Participants will also undergo feasibility interviews.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Usual CareExperimental Treatment1 Intervention
Black patients with systolic blood pressure \>140 mmHg on the last two clinic visits plus baseline systolic blood pressure \>130 mmHg - usual clinic based hypertension care using routinely available clinic services including community health worker/social worker. Clinicians can offer self-management support (e.g., dietician referral) or recommend a home blood pressure monitor. These activities mirror current primary care practice.
Group II: Team based Equity conscious Telemedicine Hypertension (TET-HTN) interventionExperimental Treatment1 Intervention
Black patients with systolic blood pressure \>140 mmHg on the last two clinic visits plus baseline systolic blood pressure \>130 mmHg - deliver the TET-HTN intervention over six months
Group III: Interview GroupExperimental Treatment1 Intervention
Black patients or their family members; Black community faith leaders; primary care providers and research coordinators

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security